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g.2014.0Abstract Background: Numerous studies of autistic individuals have revealed evidence of cerebral
hypoperfusion, neuroinﬂammation, gastrointestinal inﬂammation, immune dysregulation, oxida-
tive stress, relative mitochondrial dysfunction, and neurotransmitter abnormalities. Many of these
ﬁndings have been correlated with core autistic symptoms. For example, cerebral hypoperfusion in
autistic children has been correlated with repetitive, self-stimulatory and stereotypical behaviors,
and impairments in communication. Speciﬁcally, hyperbaric oxygen therapy (HBOT) has been used
and can compensate for decreased blood ﬂow by increasing the oxygen content of plasma and body
tissues. The aim of this work was to study the effect of hyperbaric oxygen therapy in autistic Egyp-
tian children.
Patients and methods: This prospective clinical trial study was conducted on 20 children diag-
nosed as autism based on DSM-IV-TR criteria (diagnostic and statistical manual of mental disor-
ders, 4th edition criteria, text revised). All patients received at least 20 sessions of hyperbaric oxygen
therapy. Sessions were done at pressure 1.5 ATA (atmosphere absolute) with 100% oxygen concen-
tration each lasting for 1–1.5 h either in multiplace chamber or monoplace chamber. MRI Perfusion
of the brain was done before and after at least 20 HBOT sessions only for 6 cases.
Results: There was a statistically signiﬁcant increase in the ratio of regional cerebral blood ﬂow
(RCBF) to white matter after HBOT in different brain regions when compared to their levels before
HBOT.
Conclusion: HBOT is a treatment that has recently become quite popular in the autism spectrum
disorder (ASD) community. Its beneﬁts cross a wide range of autistic traits as: improved language,ouad El Bedwani, 8th Zone,
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156 F. El-baz et al.increased awareness, behavior and socialization by affecting the pathophysiological ﬁndings in aut-
ism.
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Autism is a neuro-developmental disorder in the category of
pervasive developmental disorders, characterized by problems
of social communication, inﬂexible language and behavior,
and repetitive sensory-motor movements [1]. Numerous studies
of autistic individuals have revealed evidence of cerebral hypo-
perfusion, neuro-inﬂammation, gastrointestinal inﬂammation,
immune dysregulation, oxidative stress, relative mitochondrial
dysfunction, neurotransmitter abnormalities, impaired detoxi-
ﬁcation of toxins, and impaired production of porphyrins.
Many of these ﬁndings have been correlated with core autistic
symptoms. For example, cerebral hypoperfusion in temporal
regions and other brain areas in autistic children has been cor-
related with repetitive, self-stimulatory and stereotypical
behaviors, and impairments in communication [2,3].
Hyperbaric oxygen therapy (HBOT) might be able to im-
prove each of these problems in autistic individuals [4]. Specif-
ically, HBOT has been used and can compensate for decreased
blood ﬂow by increasing the oxygen content of plasma and
body tissues. HBOT has been reported to possess strong
anti-inﬂammatory properties and has been shown to improve
immune function. There is evidence that oxidative stress can
be reduced with HBOT through the upregulation of antioxi-
dant enzymes. HBOT can also increase the function and pro-
duction of mitochondria and improve neurotransmitter
abnormalities. In addition, HBOT upregulates enzymes that
can help with detoxiﬁcation problems and impaired produc-
tion of porphyrins in autistic children which might affect the
production of heme, so, HBOT might help to overcome the ef-
fects of this problem [5]. HBOT has been shown to mobilize
stem cells from the bone marrow to the systemic circulation.
Recent studies in humans have shown that stem cells can enter
the brain and form new neurons, astrocytes, and microglia. It
is expected that amelioration of these underlying pathophysio-
logical problems through the use of HBOT will lead to
improvements in autistic symptoms [6]. The aim of this work
was to study the effect of hyperbaric oxygen therapy in autistic
Egyptian children.
2. Patients and methods
This prospective clinical trial study was conducted on twenty
children diagnosed as autism based on DSM-IV-TR criteria
(diagnostic and statistical manual of mental disorders, 4th edi-
tion criteria, text revised) who attended for follow up at the
Psychiatry Clinic, Children Hospital, Ain Shams University.
The patient’s group included 17 males and 3 females, their ages
ranged from 2 to 9 years (mean age 5.6, SD ±2.11 years).
Children were allowed to continue all current therapies dur-
ing HBOT.
All patients were subjected to the following:
(I) Detailed history taking with special emphasis on:Onset,
course, duration of the disease, age, sex of the patient,
antenatal, natal, postnatal history, developmental his-tory (both mental and motor) and accurate details of
cognitive abilities and gross and ﬁne motor function,
past history and family history concerning similar condi-
tion or any psychological or mental disorders. Also his-
tory of major childhood illnesses, surgery, injuries, diet,
and medication was taken.
(II) Thorough clinical examination with special emphasis on
neurological examination.
(III) Psychiatric evaluation includes:(1) Conﬁrmation of diagnosis using DSM-IV-TR cri-
teria [7,8].
(2) Childhood autism rating scale (CARS) was done
before and after at least 20 sessions of HBOT [9].The scale is used to observe and subjectively rate 15 items.
Relationship to people, imitation, emotional response, body
use, object use, adaptation to change, visual response, listening
response, taste–smell–touch response and use, fear and ner-
vousness, verbal communication, non-verbal communication,
activity level, level and consistency of intellectual response
and general impressions. Each of the ﬁfteen criteria listed
above is rated with a score of Normal for child’s age, mildly
abnormal, moderately abnormal, and severely abnormal. To-
tal CARS scores range from 15 to 60, score of 30 is considered
the cutoff level for a diagnosis of autism on the mild end of the
autism spectrum (done before and after at least 20 sessions of
hyperbaric oxygen therapy).
(3) Autism treatment evaluation checklist (ATEC) was done
before and after at least 20 sessions of HBOT [10].
The ATEC is a questionnaire that was developed by the
Autism Research Institute to evaluate the treatment efﬁcacy
in autistic individuals. It consists of four subscales labeled:
Speech/Language/Communication, Sociability, Sensory/Cog-
nitive Awareness, and Health/Physical/Behavior. The scores
are weighted according to the response and the corresponding
subscale. The higher the subscale and total scores, the more
impaired the subject [11]. ATEC is used in some studies as
an outcome measure [12]. It is designed to allow parents and
physicians to assess the outcomes of certain treatments com-
monly used in autistic individuals. In this study, scores were
calculated for the total score and the four separate subscales
(done before and after at least 20 sessions of hyperbaric oxygen
therapy).
(IV) Hyperbaric oxygen therapy:
All patients received at least 20 sessions of hyperbaric oxy-
gen therapy (8 patients received 20 sessions, one patient re-
ceived 30 sessions and 11 patients received 20 sessions
followed by another 20 sessions after 2 weeks). Sessions were
done at pressure 1.5 ATA (atmosphere absolute) with 100%
oxygen concentration, each lasting for 1–1.5 h either in multi-
place chamber or monoplace chamber [13].
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by a parent or adult caregiver. The parents signed a written
consent before starting the therapy.
The work has been carried out in accordance with the code
of Ethics of the World Medical Association (Declaration of
Helsinki) for experiments involving humans.
(V) MRI Perfusion of the brain
It was done before and after at least 20 HBOT sessions for 6
cases. MRI perfusion was performed with a 1.5 Tesla signa
unit (Philips entera Medical Systems). A multisection T2-
weighted gradient echo was applied to obtain axial images.
The size of imaging ﬁeld of view corresponds to (fov)
240 · 240 with head sense coil.
The paramagnetic contrast agent used is Gadolinum
DTPA which was injected intravenously (5–10 cc) and in-
jected after obtaining the ﬁrst three dynamic series while
obtaining 37 dynamic series. Five bilateral brain areas (fron-
tal, superior temporal, deep temporal, thalami and prefron-
tal) were visually assessed. The images were transferred to a
work station called extended MRI work station (EWS) for
post processing. Regional cerebral blood ﬂow (RCBF) in
Ml/sec was assessed by scaling the color of the speciﬁc area
to color scale present in the image given. Ratio of RCBF
to the white matter (corona radiate) of the brain at the level
of the thalamus is obtained as global differences in RCBF be-
tween scans by proportional scaling due to time zone between
the pre HBOT MRI perfusion and the post HBOT MRI per-
fusion as the white matter perfusion is a constant (this is
done by comparing the color to the scale in the edge of the
image.)Table 1 Demographic data of the patients.
Age of patients
<5 years
5–9 years
Age at diagnosis
1–3 years
3–6 years
Sex M/F
Clinical types of ASD (AD/AS/RETT)
Classiﬁcation of patients according to CARS scores
Mild (21–27)
Moderate (28–33)
Severe > 34
Treatment
Speech therapy
Behavioral therapy
Risperdal
Antifungal
Casein gluten free diet
Antioxidants, vitamins
Chelation
Antiepileptic (Tegretol)
ASD: autistic spectrum disorder.
AD: typical autism.
AS: asperger syndrome.
HBOT: hyperbaric oxygen therapy.2.1. Statistical methodology
Data are expressed as mean ± SD (range) or as number (%)
of cases. Comparison between parameters of ATEC and
CARS pre and post HBOT was performed using paired t test,
the relationship with other parameters was obtained by a Pear-
son correlation coefﬁcient. Comparison between ratio of
RCBF to white matter pre and post therapy was tested by
the Wilcoxon Signed Rank Test for six cases only. Analysis
was performed by using the Statistical Package for the Social
Sciences (SPSS, version 15). The level P < 0.05 was considered
the cut-off value for signiﬁcance.
3. Results
This study included 20 Egyptian autistic patients (AD), there
were 17 males (85%), and 3 females (15%) with male to female
ratio 5.6:1, their ages ranged from 2 to 9 years, with a mean
age 5.6, SD ± 2.11 years. Fifteen patients (75%) were diag-
nosed before the age of 3 years, while 5 of them (25%) were
diagnosed after the age of three years. In the current study,
90% of patients were on speech therapy, 55% were on behav-
ioral therapy, 30% were on risperdal, 15% were on casein, glu-
ten free diet and 75% were on multivitamins. In our study
100% of moderate cases changed to the mild degree, 6% of se-
vere cases changed to mild degree and 31% of severe cases
changed to moderate so the lesser the degree of autism the
more is the response (Table 1).
There was a statistical signiﬁcant decrease i.e., improve-
ment in communication, sociability, cognitive awareness,
behavior, total score, CARS post HBOT when compared to
their level before HBOT P < 0.001. The more the decreaseNo/%
6 (30%)
14(70%)
15 (75%)
5 (15%)
17/3 (85% vs. 15%)
20/0/0
Pre HBOT post HBOT
0 5 (25%)
4 (30%) 5 (25%)
16 (70%) 10 (50%)
No/%
18 (90%)
11 (55%)
6 (30%)
9 (45%)
3 (15%)
15 (75%)
3 (15%)
2 (10%)
Table 2 Statistical comparison between ATEC and CARS pre and post HBOT.
ATEC Pre HBOT Post HBOT T P Improvement (%) Sig.
Mean ±SD Mean ±SD
Communication 17.25 7.07 12.40 6.68 6.25 <0.001 29.4 HS
Sociability 19.80 7.98 12.50 6.43 6.29 <0.001 36.8 HS
Cognitive awareness 21.00 6.10 16.35 5.36 6.43 <0.001 22.1 HS
Behavior 14.80 8.56 9.10 6.22 4.83 <0.001 38.5 HS
Total score 72.40 21.57 49.10 17.98 12.52 <0.001 32.1 HS
CARS 37.95 5.27 32.20 6.74 7.44 <0.001 15.1 HS
ATEC: autism treatment evaluation checklist.
CARS: childhood autism rating scale/HBOT: hyperbaric oxygen therapy.
HS: highly signiﬁcant.
Figure 1 Histogram showing ATEC subscales pre and post
HBOT. It is evident that there is improvement in all ATEC
subscales (communication, sociability, cognitive awareness and
behavior).
Figure 2 Histogram showing ATEC (total score) and CARS pre
and post HBOT. It is evident that there is improvement in both
ATEC total score and CARS.
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2. In our study ATEC scores improved by 25.8% in the youn-
ger age group compared to 34% in the older age group, CARS
improved by 15.4% in the younger age group and 15% in the
older age group (Table 3).
Cases with behavioral therapy showed signiﬁcantly lower
mean Cognitive awareness score (meaning increase in mental-
ity) pre and post HBOT, total score (post HBOT) and CARS
(post HBOT) when compared to cases without behavioral
therapy P < 0.05.There was no statistical signiﬁcant difference
between cases with and without behavioral therapy as regards
the other ATEC parameters pre and post HBOT P > 0.05.
There was no statistical signiﬁcant difference between cases
with and without casein gluten free diet, respadex, speech ther-
apy, as regards the ATEC subscales, total score and CARS pre
and post HBOT P > 0.05. There was no correlation between
age, age at diagnosis, number of sessions and ATEC subscales,
total score, CARS post HBOT P > 0.05. There was a statisti-
cal signiﬁcant increase in the ratio of RCBF (regional cerebral
blood ﬂow) to white matter after HBOT in left thalamic re-
gion, right prefrontal region, left prefrontal region, right fron-
tal region, left frontal region, right superﬁcial temporal region
(Figs. 3–5), as well as left superﬁcial temporal region when
compared to their levels before HBOT P < 0.05. The ratio
of RCBF to white matter after HBOT showed increase in right
thalamic region when compared to the level before HBOT but
the difference did not reach a signiﬁcant level P = 0.07. There
was no statistically signiﬁcant difference before and afterHBOT as regards the ratio of RCBF to white matter in right
and left deep temporal regions P > 0.05.
4. Discussion
Autism Spectrum Disorders (ASDs) are characterized by the
presence of impaired development in social interaction and
communication and the presence of a restricted activity and
interests [14]. The etiology of ASD is not currently known,
which may in part explain why numerous widely divergent
treatments for ASDs are in regular use. While genetic factors
are clearly important, as indicated by high concordance rates
among twins and siblings, they alone cannot account for an
epidemic that developed in the relatively short period of 10–
20 years, however, environmental factors are very likely to
account for the major portion of the increased prevalence of
autism as many studies showed the presence of higher levels
of heavy metals especially mercury in the hair of children with
autism as compared to the age and sex matched healthy con-
trol [15]. Cerebral hypoperfusion in temporal regions and
other brain areas in autistic children has been correlated with
repetitive, self-stimulatory and stereotypical behaviors, and
impairments in communication. Hyperbaric oxygen therapy
(HBOT) might be able to improve each of these problems in
autistic children [4]. Speciﬁcally, HBOT has been used and
can compensate for decreased blood ﬂow by increasing the
oxygen content of plasma and body tissues. HBOT has been
reported to possess strong anti-inﬂammatory properties and
has been shown to improve immune function [16]. HBOT
Table 3 Percentage of average score improvement by age.
Age (years) ATEC pre HBOT ATEC POST HBOT Improvement (%) CARS PRE HBOT CARS POST HBOT Improvement %()
<5 81.25 60.25 25.8 40.37 34.12 15.4
P5 70.18 46.31 34 37.3 31.7 15
Figure 3 Histogram showing the ratio of RCBF to white matter
pre and post HBOT in different brain areas bilaterally. It is
evident that there is increase in regional cerebral blood ﬂow after
HBOT in different brain areas.
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ing more oxygen to the brain and by causing angiogenesis of
new blood vessels over time by increasing Vascular Endothelial
Growth Factor (VEGF) levels [17,18]. HBOT has been shown
to decrease the inﬁltration of polymorphnuclear leucocytes
(PMN’s) after an ischemic injury to the brain [19]. In addition,
HBOT inhibits neutrophil attachment to blood vessel walls
[20] and increases the distance that oxygen can travel in the
interstitial space [21]. Treatment with HBOT has been shown
to possess potent anti-inﬂammatory properties in both animal
[22,23] and human studies [24,25]. HBOT has been reported to
decrease the production of pro-inﬂammatory cytokines
(including TNF-alpha, interferon-gamma, IL-1 and IL-6) in
both animal [26,27] and human studies [28] as well as to in-
crease counter-inﬂammatory IL-10 levels [29]. In one study,
HBOT also decreased neopterin levels [30]. The effect of
HBOT on reducing inﬂammation may be mediated through
a pressure-related effect and not necessarily by the oxygen
delivered. The rationale for using HBOT for the treatment of
ASDs is based on the recent ﬁndings of oxidative stress [31]
and neuroinﬂammation [32] in ASDs and initial evidence that
HBOT may alleviate oxidative stress in rats with pancreatitis
[33] and decrease inﬂammatory responses in rats [34].This study was conducted on 20 autistic children, 75% of
autistic children were diagnosed before the age of 3 years,
while the remaining 25% were diagnosed after the age of three
years. Autistic group’s age ranged from 2 to 9 years with an
average age 5.68 years. These ﬁndings are in agreement with
Jonson, CP who found that a delay in child’s starting to speak
around age two brings problems to parents’ attention, even
though other, less noticeable signs may be present at an earlier
age [35]. Other studies reported that parents are often aware of
developmental problems in their child from age 18 months, but
a diagnosis is often not made until 2 years after the initial
expression of parental concern. In some cases diagnosis has
not been conﬁrmed until close to age 6 years, which is some-
times associated with delays attributable to access to services
and regional variations in diagnosis [36]. In the current study
85% of autistic children were males, and 15% were females,
with male/female ratio 5.6:1, and this goes with other studies,
one of them involved 2685 patients with autism, the prevalence
was more in males than females (ratio of 3.4–6.5) [37], while
other investigators reported male:female ratio 2.8–5.5 [38].
Concerning ASD in the present study, 100% of the autistic
group were typically autistic (AD). Ninety patients were on
speech therapy, 55% were on behavioral therapy, 30% were
on risperdal, 15% were on casein and gluten free diet, and
75% were on multivitamins. The key non-biomedical therapy
employed by the majority of parents surveyed was speech ther-
apy (75.3%), the next most frequently used therapies were ap-
plied behavioral analysis (ABA) and sensory integration which
were used by 34.7% and 28.8% respectively. Approximately
50–60% of children were on one of the commonly used diets,
e.g., Gluten/Casein Free, Gluten/Casein/Soy free, sugar re-
moved, chocolate removed, and Speciﬁc Carbohydrate Diet.
In our study, signiﬁcant improvement was observed in the
ATEC scale in total score, subscales (sociability, sensory/cog-
nitive awareness, and health/physical/behavior, communica-
tion) and CARS after completing at least twenty sessions of
HBOT at 1.5 ATA and 100% oxygen. The average improve-
ment of ATEC total score in all children was 32.1%, and the
average improvement of CARS score in all children was
15.1%. In another study, in which six children completed 40,
1 h sessions of low pressure HBOT at 1.3 ATA and 28–30%
oxygen, reported an average improvement of ATEC total
score in all children as 22.1%, the average improvement of
CARS score in all children as 12.1% [6].
As regard to CARS, in our study 100% of moderate cases
of autism changed to the mild degree, 6% of severe cases also
changed to the mild degree, 31% of severe cases changed to the
moderate degree, so the lesser the degree of autism the more is
the response. In our study ATEC scores also improved by
25.8% in the younger age group compared to 34% in the older
age group, and CARS improved by 15.4% in the younger age
group and 15% in the older age group. In contrary to our
study, other researchers reported that ATEC scores improved
by 31.6% in the younger age group compared to 8.8% in the
Figure 4 MRI brain perfusion in different brain areas (A) prefrontal area, (B) deep temporal area, (C) thalamic area, (D) frontal and
superﬁcial temporal area before HBOT.
Figure 5 MRI brain perfusion in different brain areas (A) prefrontal area, (B) deep temporal area, (C) thalamic area, (D) frontal and
superﬁcial temporal area after HBOT showing increased regional cerebral blood ﬂow in all brain areas.
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ger age group and 5.6% in the older age group [6]. Our results
may be explained by small number of young aged patients (6
patients), however, Golden et al. [39] reported that younger
patients tend to have improvements more quickly than older
patients. It was proved that older children with autism gener-
ally have a higher degree of cerebral hypoperfusion compared
to younger children and that hyperbaric oxygen treatment can
improve cerebral hypoperfusion [40].
In our study there was no correlation between the number
of sessions and both ATEC and CARS post HBOT. On the
other hand, other researchers have noted that 50–80 HBOT
sessions are typically needed to show signiﬁcant clinical gains
[41]. In our study cases with behavioral therapy showed signif-
icant improvement in both ATEC total score (post HBOT)
and CARS (post HBOT) when compared to cases without
behavioral therapy. In comparison to a recent meta-analysis
of studies on early intensive behavioral interventions it was
found that the potential effects of HBOT were not additive
to the effects of ABA [42].
In our study there was no statistical signiﬁcant difference
between cases with and without multivitamins as regards the
ATEC and CARS pre and post HBOT, and this agrees with
other study that involved 18 children with autism, who under-
went 40 hyperbaric sessions of 45 min duration each at either
1.5 atmospheres (atm) and 100% oxygen, and found that chil-
dren had similar changes in clinical outcomes whether they
were or not taking folinic acid and/or methylcobalamin [13].
Regarding MRI perfusion of the brain for the patients,
there was a statistically signiﬁcant increase in the ratio of
RCBF to white matter after HBOT in the left thalamic region,
right prefrontal region, left prefrontal region, right frontal re-
gion, left frontal region, right superﬁcial temporal region, left
superﬁcial temporal region when compared to their levels be-
fore HBOT. The ratio of RCBF to white matter after HBOT
also showed increase in right thalamic region when compared
to the level before HBOT but the difference did not reach a sig-
niﬁcant level. There was no statistically signiﬁcant difference in
the ratio of RCBF to white matter in right and left deep tem-
poral regions before and after HBOT. In agreement with our
study, an improvement in cerebral hypoperfusion as measured
by SPECT scans in an autistic child after hyperbaric oxygen
therapy at 1.3 atm was noted. As HBOT may improve assorted
areas of cerebral hypoperfusion, and since these areas may
additionally differ in location from child to child, various clin-
ical outcomes could occur [43]. In our study there was a nega-
tive correlation between Cognitive awareness score (lower
mean cognitive awareness score means increase in mentality)
and ratio of RCBF to white matter in left deep temporal region
pre HBOT, post HBOT and between behavior score and ratio
of RCBF to white matter in right and left thalamic region, left
prefrontal region and right deep temporal region post HBOT.
Other studies showed that the dysfunction of the superior tem-
poral sulcus may indirectly explain the emotional and cogni-
tive components of autism [44].
Also, Starkestein et al. [2] studied 30 individuals with aut-
ism compared to 14 non-autistic individuals. Hypoperfusion
of the thalamus as measured by Single Photon Emission Com-
puterized Tomography (SPECT) was observed in the autism
group and signiﬁcantly correlated with repetitive behaviors
and unusual sensory interests. Also, a SPECT study of 23 chil-
dren with autism was compared to 26 non-autistic children,hypoperfusion of the right medial temporal lobes was found
in the autism group and was correlated with obsessive desire
for sameness and hypoperfusion of the medial prefrontal cor-
tex and anterior cingulate gyrus was associated with impair-
ments in social interaction and communication [45]. In our
study there was no correlation between the patients’ ages
and ratio of RCBF to white matter either pre and post HBOT
[46]. However, other studies showed that hypoperfusion of the
prefrontal and left temporal areas worsened and became
‘‘quite profound’’ in autistic children as the age of the autistic
child increased. This diminished perfusion correlated with de-
creased language development. The authors concluded that
hypoperfusion ‘‘subsequently prevents development of true
verbal ﬂuency and development in the temporal and frontal
areas associated with speech and communication’’ [47].
In conclusion, HBOT is a treatment that has recently be-
come quite popular in the ASD community. Its beneﬁts cross
a wide range of autistic traits as: it improves language, in-
creases awareness, behavior and socialization. We recommend
that the child should undergo a minimum of 40 sessions. Some
children may require up to 80 sessions to see beneﬁts. HBOT
can be used for any age but a better effect is obtained with
early intervention and any degree of autism. However a better
effect is obtained with mild and moderate cases. Further re-
search is needed on a large scale in this area being a new
modality of treatment in autistic patients.
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